Apr 27, 2017 12:01 pm UTC| Business
BLOOMFIELD HILLS, Mich., April 27, 2017 -- TriMas (NASDAQ:TRS) today announced financial results for the quarter ended March31, 2017. TriMas reported first quarter net sales of $199.8 million, a decrease of 1.5%...
Apr 27, 2017 12:01 pm UTC| Business
SCOTTSDALE, Ariz., April 27, 2017 -- Meritage Homes Corporation (NYSE:MTH), a leading U.S. homebuilder, reported its first quarter results for the period ended March31, 2017. Summary Operating Results...
Apr 27, 2017 12:01 pm UTC| Business
SCOTTSDALE, Ariz., April 27, 2017 -- Meritage Homes Corporation (NYSE:MTH), a leading U.S. homebuilder, reported its first quarter results for the period ended March31, 2017. Summary Operating Results...
Cara Therapeutics to Announce First Quarter 2017 Financial Results on May 4, 2017
Apr 27, 2017 12:01 pm UTC| Business
STAMFORD, Conn., April 27, 2017 -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively...
Cara Therapeutics to Announce First Quarter 2017 Financial Results on May 4, 2017
Apr 27, 2017 12:01 pm UTC| Business
STAMFORD, Conn., April 27, 2017 -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively...
Apr 27, 2017 12:01 pm UTC| Business
SAN DIEGO, April 27, 2017 -- Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, today...
Apr 27, 2017 12:01 pm UTC| Business
SAN DIEGO, April 27, 2017 -- Fate Therapeutics, Inc. (NASDAQ:FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, today...